Andrew B. Nixon

Also affiliated with Duke Medical Center, Durham VA Medical Center

MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 4%percentile

0.694Author DataRank

Indexed papers

5in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 5 indexed papers attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

The highest-impact dataset this researcher has shared, ranked by DataRank — the single contribution doing the most to lift their data-sharing standing.

Predictive Biomarkers of Overall Survival in Patients with Metastatic Renal Cell Carcinoma Treated with IFNα ± Bevacizumab: Results from CALGB 90206 (Alliance)

Clinical Cancer Research(2021)10.1158/1078-0432.ccr-21-2386

Top 29%

0.694DataRank

Top 29%11 citations

Susan Halabi, Yingmiao Liu, Mark D. Starr, John C. Brady, Ivo Shterev +9 more

Papers

Driven by 46 papers — median percentile 0. Top paper: “Assessment of Capecitabine and Bevacizumab With or Without Atezolizumab for the Treatment of Refractory Metastatic Colorectal Cancer”.

Assessment of Capecitabine and Bevacizumab With or Without Atezolizumab for the Treatment of Refractory Metastatic Colorectal Cancer

JAMA Network Open(2022)10.1001/jamanetworkopen.2021.49040

N/A

3.5DataRank · unranked

127 citations

Fang‐Shu Ou, Tyler Zemla, Þorvarður R. Hálfdánarson, Heinz‐Josef Lenz, Rimini Breakstone +11 more

Predictive Biomarkers of Overall Survival in Patients with Metastatic Renal Cell Carcinoma Treated with IFNα ± Bevacizumab: Results from CALGB 90206 (Alliance)

Clinical Cancer Research(2021)10.1158/1078-0432.ccr-21-2386

Top 29%

0.694DataRank

Top 29%11 citations

Susan Halabi, Yingmiao Liu, Mark D. Starr, John C. Brady, Ivo Shterev +9 more

Lymphocyte subset abnormalities in early severe scleroderma favor a Th2 phenotype and are not altered by prior immunosuppressive therapy

Lara D. Veeken(2022)10.1093/rheumatology/keac015

N/A

0.607DataRank · unranked

10 citations

Jan Storek, Rob Woolson, Ashley Pinckney, Lynnette Keyes-Elstein, Paul K. Wallace +21 more

Single-cell and spatial detection of senescent cells using DeepScence

bioRxiv (Cold Spring Harbor Laboratory)(2023)10.1101/2023.11.21.568150

N/A

0.479DataRank · unranked

11 citations

Beijie Ji, Runze Dong, Liangcai Gu, Cliburn Chan, Jichun Xie +5 more

A randomized trial of consolidation-targeted adjuvant therapy with encorafenib and cetuximab versus usual care for patients with stage II/III BRAF V600E colon cancer: Alliance for Clinical Trials in Oncology A022004.

Journal of Clinical Oncology(2023)10.1200/jco.2023.41.16_suppl.tps3641

N/A

0.353DataRank · unranked

6 citations

Qian Shi, Amylou C. Dueck, Elie G. Dib, Syed Mohammad Ali Kazmi, Olatunji B. Alese +6 more

A phase II, multicenter, single-arm study of pemigatinib in patients with metastatic or unresectable colorectal cancer harboring FGFR alterations

The Oncologist(2025)10.1093/oncolo/oyaf069

N/A

0.232DataRank · unranked

3 citations

Tyler Zemla, Joleen M. Hubbard, John H. Strickler, Olumide B. Gbolahan, L. R. Wilson +6 more

CALGB 80802 (Alliance): Impact of Sorafenib with and without Doxorubicin on Hepatitis C Infection in Patients with Advanced Hepatocellular Carcinoma

Cancer Research Communications(2024)10.1158/2767-9764.crc-22-0516

N/A

0.216DataRank · unranked

2 citations

Susan M. Geyer, Andrew B. Nixon, Federico Innocenti, Qian Shi, Priya Kumthekar +16 more

Gene expression biomarkers differentiate overall survival of colorectal cancer upon targeted therapies

Research Square(2024)10.21203/rs.3.rs-4047331/v1

N/A

0.165DataRank · unranked

2 citations

Azam Yazdani, Raúl Méndez-Giráldez, Gianluigi Pillonetto, Esmat Samiei, Reza Hadi +10 more

A phase II study of savolitinib (volitinib, AZD6094, HMPL-504) in subjects with MET amplified metastatic colorectal cancer (mCRC) detected by cell-free (cf)DNA.

Journal of Clinical Oncology(2020)10.1200/jco.2020.38.4_suppl.tps270

N/A

0DataRank · unranked

3 citations

Donna Niedzwiecki, Christy Arrowood, Nancy Garett-Mead, Rebecca J. Nagy, Richard B. Lanman +4 more

Survival in Young-Onset Metastatic Colorectal Cancer: Findings From Cancer and Leukemia Group B (Alliance)/SWOG 80405

JNCI Journal of the National Cancer Institute(2021)10.1093/jnci/djab200

N/A

0DataRank · unranked

45 citations

Sui Zhang, Fang‐Shu Ou, Chao Ma, Nadine J. McCleary, Donna Niedzwiecki +16 more

Plasma Protein Biomarkers in Advanced or Metastatic Colorectal Cancer Patients Receiving Chemotherapy With Bevacizumab or Cetuximab: Results from CALGB 80405 (Alliance)

Clinical Cancer Research(2021)10.1158/1078-0432.ccr-21-2389

N/A

0DataRank · unranked

20 citations

Alexander B. Sibley, Yingmiao Liu, Ace J. Hatch, Chen Jiang, Flora Mulkey +13 more

A phase 2 trial of the somatostatin analog pasireotide to prevent GI toxicity and acute GVHD in allogeneic hematopoietic stem cell transplant

PLoS ONE(2021)10.1371/journal.pone.0252995

N/A

0DataRank · unranked

5 citations

Sharareh Siamakpour‐Reihani, Lauren Bohannan, Yi Ren, Alexander B. Sibley, Jeff Sheng +24 more

Alliance/CALGB 80802: Impact of hepatitis C (HCV) on doxorubicin (DO) + sorafenib (S) versus S in patients (pts) with advanced hepatocellular carcinoma (aHCC).

Journal of Clinical Oncology(2021)10.1200/jco.2021.39.3_suppl.325

N/A

0DataRank · unranked

2 citations

Susan M. Geyer, Andrew B. Nixon, Federico Innocenti, Qian Shi, Sawyer Jacobson +12 more

Radiomic signatures to predict survival in patients with advanced hepatocellular carcinoma (HCC) treated with sorafenib +/- doxorubicin: Correlative science from CALGB 80802 (Alliance).

Journal of Clinical Oncology(2021)10.1200/jco.2021.39.3_suppl.343

N/A

0DataRank · unranked

1 citations

Susan M. Geyer, Andrew B. Nixon, Federico Innocenti, Qian Shi, Sawyer Jacobson +12 more

Discordance between central versus local response assessments in neuroendocrine tumor (NET) patients (pts) enrolled in A021202.

Journal of Clinical Oncology(2021)10.1200/jco.2021.39.3_suppl.361

Top 100%

0DataRank

Top 100%0 citations

Michelle R. Mahoney, Timothy R. Asmis, Nathan C. Hall, Sanja Karovic, Michael V. Knopp +9 more

Influence of dietary insulin scores on survival in patients with metastatic colorectal cancer (mCRC): Findings from CALGB (Alliance) 80405.

Journal of Clinical Oncology(2021)10.1200/jco.2021.39.15_suppl.3568

N/A

0DataRank · unranked

0 citations

Chao Ma, Fang‐Shu Ou, Chen Yuan, Brendan J. Guercio, Vicente Morales‐Oyarvide +15 more

Reciprocal SOX2 regulation by SMAD1-SMAD3 is critical for anoikis resistance and metastasis in cancer

Cell Reports(2022)10.1016/j.celrep.2022.111066

N/A

0DataRank · unranked

63 citations

Mehri Monavarian, Kathleen O’Connell, Diego Altomare, Abigail Shelton, Shubham Mehta +12 more

Hypoxia-induced inhibin promotes tumor growth and vascular permeability in ovarian cancers

Communications Biology(2022)10.1038/s42003-022-03495-6

N/A

0DataRank · unranked

18 citations

Shrikant Pradhan, Roohi Chaudhary, Eduardo Listik, Liz Quintero-Macías, Alex Seok Choi +10 more

Evaluating immune response and metabolic related biomarkers pre-allogenic hematopoietic stem cell transplant in acute myeloid leukemia

PLoS ONE(2022)10.1371/journal.pone.0268963

N/A

0DataRank · unranked

3 citations

Felicia Cao, Jing Lyu, Yi Ren, Andrew B. Nixon, Jichun Xie +10 more

Circulating Angiokines Are Associated With Reverse Remodeling and Outcomes in Chronic Heart Failure

Journal of Cardiac Failure(2023)10.1016/j.cardfail.2022.12.011

N/A

0DataRank · unranked

9 citations

Andrew B. Nixon, Melissa A. Daubert, Eric Yow, James L. Januzzi, Mona Fiuzat +8 more

Alliance A021804: A prospective, multi-institutional phase II trial evaluating temozolomide versus temozolomide and olaparib for advanced pheochromocytoma and paraganglioma.

Journal of Clinical Oncology(2023)10.1200/jco.2023.41.16_suppl.tps4191

N/A

0DataRank · unranked

5 citations

Kimberly Perez, Susan M. Geyer, Maged Khalil, Aishwarya Vijendran, Andrea Kordaris-Corkill +9 more

Neoplastic and blood-based biomarkers of response in patients with advanced endometrial cancer: Results from NRG GY012.

Journal of Clinical Oncology(2023)10.1200/jco.2023.41.16_suppl.5525

N/A

0DataRank · unranked

1 citations

Andrew B. Nixon, Danielle Enserro, David Bender, B.J. Rimel, Matthew A. Powell +12 more

Data from Plasma Protein Biomarkers in Advanced or Metastatic Colorectal Cancer Patients Receiving Chemotherapy With Bevacizumab or Cetuximab: Results from CALGB 80405 (Alliance)

(2023)10.1158/1078-0432.c.6531153

Top 100%

0DataRank

Top 100%0 citations

Alexander B. Sibley, Yingmiao Liu, Ace J. Hatch, Chen Jiang, Flora Mulkey +13 more

Data from Predictive Biomarkers of Overall Survival in Patients with Metastatic Renal Cell Carcinoma Treated with IFNα ± Bevacizumab: Results from CALGB 90206 (Alliance)

(2023)10.1158/1078-0432.c.6531354

Top 100%

0DataRank

Top 100%0 citations

Susan Halabi, Yingmiao Liu, Mark D. Starr, John C. Brady, Ivo Shterev +9 more

Data from Predictive Biomarkers of Overall Survival in Patients with Metastatic Renal Cell Carcinoma Treated with IFNα ± Bevacizumab: Results from CALGB 90206 (Alliance)

(2023)10.1158/1078-0432.c.6531354.v1

Top 100%

0DataRank

Top 100%0 citations

Susan Halabi, Yingmiao Liu, Mark D. Starr, John C. Brady, Ivo Shterev +9 more

Heparan sulfate modifications of betaglycan promote TIMP3-dependent ectodomain shedding to fine-tune TGF-β signaling

bioRxiv (Cold Spring Harbor Laboratory)(2023)10.1101/2023.08.29.555364

N/A

0DataRank · unranked

0 citations

Laura M. Jenkins, Wade Barton, Asha Kumari, Carly L. Lancaster, Calen Raulerson +12 more

Common variation in a long non-coding RNA gene modulates variation of circulating TGF- β 2 levels in metastatic colorectal cancer patients (Alliance)

medRxiv(2023)10.1101/2023.12.04.23298815

N/A

0DataRank · unranked

0 citations

Alexander B. Sibley, Yingmiao Liu, Donna Niedzwiecki, Susan Halabi, Layne Rogers +10 more

Glycosaminoglycan modifications of betaglycan regulate ectodomain shedding to fine-tune TGF-β signaling responses in ovarian cancer

Cell Communication and Signaling(2024)10.1186/s12964-024-01496-y

N/A

0DataRank · unranked

6 citations

Laura M. Jenkins, Wade Barton, Asha Kumari, Carly L. Lancaster, Calen Raulerson +12 more

Prognostic and predictive analyses of circulating plasma biomarkers in men with metastatic castration resistant prostate cancer treated with docetaxel/prednisone with or without bevacizumab

Prostate Cancer and Prostatic Diseases(2024)10.1038/s41391-024-00794-3

N/A

0DataRank · unranked

3 citations

Yingmiao Liu, Qian Yang, Bin Luo, Mark D. Starr, John C. Brady +7 more

Common variation in a long non-coding RNA gene modulates variation of circulating TGF-β2 levels in metastatic colorectal cancer patients (Alliance)

BMC Genomics(2024)10.1186/s12864-024-10354-7

N/A

0DataRank · unranked

1 citations

Alexander B. Sibley, Yingmiao Liu, Donna Niedzwiecki, Susan Halabi, Layne Rogers +10 more

Common variation in a long non-coding RNA gene modulates variation of circulating TGF-β2 levels in metastatic colorectal cancer patients (Alliance)

UNC Libraries(2024)10.17615/m9fj-sb76

N/A

0DataRank · unranked

0 citations

Alan P. Venook, William Kevin Kelly, Andrew B. Nixon, Mark J. Ratain, Howard L. McLeod +10 more

B-Lightning: using bait genes for marker gene hunting in single-cell data with complex heterogeneity

Briefings in Bioinformatics(2024)10.1093/bib/bbaf033

N/A

0DataRank · unranked

0 citations

Qi Gao, Liuyang Wang, Dongmei Li, Andrew B. Nixon, Cliburn Chan +3 more

Single-cell and spatial detection of senescent cells using DeepScence

Cell Genomics(2025)10.1016/j.xgen.2025.101035

N/A

0DataRank · unranked

6 citations

Bing Ji, Runze Dong, Liangcai Gu, Cliburn Chan, Jichun Xie +5 more

Gene signatures derived from transcriptomic-causal networks stratify colorectal cancer patients for effective targeted therapy

Communications Medicine(2025)10.1038/s43856-024-00728-z

N/A

0DataRank · unranked

6 citations

Heinz‐Josef Lenz, Gianluigi Pillonetto, Raúl Méndez-Giráldez, Hanna K. Sanoff, Reza Hadi +17 more

Circulating immune biomarkers correlating with response in patients with metastatic renal cell carcinoma on immunotherapy

JCI Insight(2025)10.1172/jci.insight.185963

N/A

0DataRank · unranked

5 citations

Eda K. Holl, Yuan Wu, Anika Agarwal, Mark D. Starr, M. Martinez +7 more

Radiomic signatures to estimate survival in patients with advanced hepatocellular carcinoma treated with sorafenib: Cancer and Leukemia Group B 80802 (Alliance)

ESMO Open(2025)10.1016/j.esmoop.2025.105848

N/A

0DataRank · unranked

1 citations

Susan M. Geyer, Andrew B. Nixon, Federico Innocenti, Q. Shi, Steven Jacobson +15 more

Novel treatment-specific causal biomarkers for colorectal cancer by omics integration

NAR Genomics and Bioinformatics(2025)10.1093/nargab/lqaf053

N/A

0DataRank · unranked

0 citations

Azam Yazdani, Raúl Méndez-Giráldez, Gianluigi Pillonetto, Esmat Samiei, Reza Hadi +9 more

A tumor-intrinsic PD-L1/NLRP3 inflammasome signaling pathway drives resistance to anti–PD-1 immunotherapy

Journal of Clinical Investigation(2020)10.1172/jci133055

N/A

0DataRank · unranked

251 citations

Kathy S. Evans, Nicholas C. DeVito, Michael P. Plebanek, Michael Sturdivant, Luke P. Wachsmuth +10 more

Gene signatures derived from transcriptomic-causal networks stratify colorectal cancer patients for effective targeted therapy

UNC Libraries(2025)10.17615/rbz3-7m15

N/A

0DataRank · unranked

0 citations

Scott Kopetz, Rashid, Naim U, Mark J. Ratain, Esmat Samiei, Federico Innocenti +18 more

Combination of PARP Inhibitor Olaparib, and PD-L1 Inhibitor Durvalumab, in Recurrent Ovarian Cancer: a Proof-of-Concept Phase II Study

Clinical Cancer Research(2020)10.1158/1078-0432.ccr-20-0056

N/A

0DataRank · unranked

224 citations

Alexandra S. Zimmer, Michelle R. Padget, Ashley Cimino‐Mathews, Jayakumar R. Nair, Yingmiao Liu +13 more

Predictive Blood-Based Biomarkers in Patients with Epithelial Ovarian Cancer Treated with Carboplatin and Paclitaxel with or without Bevacizumab: Results from GOG-0218

Clinical Cancer Research(2020)10.1158/1078-0432.ccr-19-0226

N/A

0DataRank · unranked

57 citations

Kirsten B. Burdett, Kouros Owzar, David Tritchler, Alexander B. Sibley, Yingmiao Liu +16 more

Blood-based markers of efficacy and resistance to cetuximab treatment in metastatic colorectal cancer: results from CALGB 80203 (Alliance)

UNC Libraries(2020)10.17615/j1vn-2e47

N/A

0DataRank · unranked

7 citations

Ace J. Hatch, Alexander B. Sibley, Andrew B. Nixon, J. Chris Brady, Jingquan Jia +9 more

IGF-Binding Proteins, Adiponectin, and Survival in Metastatic Colorectal Cancer: Results From CALGB (Alliance)/SWOG 80405

JNCI Cancer Spectrum(2020)10.1093/jncics/pkaa074

N/A

0DataRank · unranked

9 citations

Sui Zhang, Fang‐Shu Ou, Alan P. Venook, Donna Niedzwiecki, Heinz‐Josef Lenz +17 more

Preliminary efficacy data of platinum-pretreated small cell lung cancer (SCLC) cohort of NCI 9881 study: A phase II study of cediranib in combination with olaparib in advanced solid tumors.

Journal of Clinical Oncology(2020)10.1200/jco.2020.38.15_suppl.9065

N/A

0DataRank · unranked

10 citations

Navid Hafez, Hatem Soliman, Siqing Fu, Shumei Kato, Primo N. Lara +12 more

Preliminary efficacy data of triple-negative breast cancer cohort of NCI 9881 study: A phase II study of cediranib in combination with olaparib in advanced solid tumors.

Journal of Clinical Oncology(2020)10.1200/jco.2020.38.15_suppl.1077

N/A

0DataRank · unranked

7 citations

Hatem Soliman, Siqing Fu, Karen A. Gelmon, Albiruni Ryan Abdul Razak, Pamela N. Münster +11 more

Alliance A151804: Establishment of a national biorepository to advance studies of immune-related adverse events.

Journal of Clinical Oncology(2020)10.1200/jco.2020.38.15_suppl.tps3154

N/A

0DataRank · unranked

5 citations

Elad Sharon, Jennifer Le‐Rademacher, Erin Twohy, Tyler Zemla, Yujia Wen +8 more

Andrew B. Nixon

Indexed papers

Top data-sharing exemplar

Papers